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Background: In South Africa, it is estimated that only 0.5-6% of people’s contacts occur in 
clinics. Both people with infectious tuberculosis and people with increased susceptibility to 
disease progression may spend more time in clinics however, increasing the importance of 
clinic-based transmission to overall disease incidence. 
Methods: We developed an illustrative mathematical model of Mycobacterium tuberculosis 
transmission in clinics and other settings. We assumed that 1% of contact time occurs in 
clinics. We varied the ratio of clinic contact time of HIV positive people compared to HIV 
negative people, and of people with infectious tuberculosis compared to people without 
tuberculosis, while keeping the overall proportion of contact time occurring in clinics, and 
each person’s total contact time, constant. 
Results: With clinic contact rates 10 and 5 times higher in HIV positive people and people 
with tuberculosis respectively, 10.7% (plausible range: 8.5%-13.4%) of tuberculosis resulted 
from transmission in clinics. With contact rates in HIV positive people and people with 
tuberculosis 5 and 2 times higher respectively, 5.3% (4.3%-6.3%) of all tuberculosis was due 
to transmission in clinics. 
Conclusion: The small amounts of contact time that occur in clinics may greatly 







There is considerable evidence that Mycobacterium tuberculosis (Mtb) transmission occurs 
in clinics and other healthcare settings in South Africa and elsewhere. A recent systematic 
review of tuberculosis in healthcare workers found that, in eight high burden countries, 
tuberculosis disease incidence in healthcare workers was 2.0-11.9 times higher than 
tuberculosis disease incidence in the general population1. In KwaZulu-Natal, South Africa, 
the incidence of multi-drug-resistant tuberculosis hospitalisation in health-care workers was 
5.5 times higher than that of non-HCW2. 
The elevated risk of tuberculosis in healthcare workers suggests that Mtb transmission 
occurs frequently in clinics. This transmission is unlikely to be confined to healthcare 
workers, with patients and other people attending clinics also likely to be at risk3. Members 
of the general population spend far less time in clinics than healthcare workers, however. 
One study of residents of a township near Cape Town, South Africa found that health clinics 
contributed 0.5% of indoor contacts (people present in the same indoor location or 
transport), and 0.7% of indoor time4. In another study (of adults only), 6.0% of indoor 
contacts and 5.1% of indoor contact hours occurring in locations outside respondents’ own 
homes were in clinics in Western Cape, South Africa, and 6.4% and 5.2% respectively in 
Zambia.5  
These low proportions of contacts and contact time in clinics suggest that clinic-based 
transmission may contribute little to overall community-wide transmission in these settings. 
This may underestimate the importance of clinic-based transmission to overall disease 
incidence, however, as both people with potentially infectious tuberculosis and people with 
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increased susceptibility to disease progression may have higher amounts of contact time in 
clinics. 
One study in Eastern Cape Province, South Africa, estimated that 63%–79% of people with 
tuberculosis attending primary health clinics for tuberculosis-related symptoms, and 90%–
100% of those attending a clinic for other reasons, were not diagnosed with tuberculosis 
during their visit, likely necessitating further clinic visits6. Another study in South Africa 
found a prevalence of tuberculosis of 3.0% among clinic patients attending for HIV care7. In 
a study in Tanzania, 48% of tuberculosis patients had sought care at a healthcare facility in 
relation to their tuberculosis symptoms three or more times before diagnosis8. These 
studies suggest that people with tuberculosis usually make multiple trips to clinics before 
being diagnosed and starting treatment, and that the prevalence of untreated, infectious 
tuberculosis in clinic attendees may be higher than that in the general population. 
Clinic attendance is also higher in people living with HIV, who have increased susceptibility 
to tuberculosis disease progression. South African 2017 national HIV management 
guidelines recommend three-monthly adherence counselling visits9, necessitating frequent 
clinic visits by people living with HIV who are receiving antiretroviral therapy. In Zambia, 
antiretroviral therapy (ART) patients had a median appointment interval of only 59 days10.  
Increased rates of clinic visiting and/or time spent in clinics by people with infectious 
tuberculosis and people living with HIV (or other risk factors for tuberculosis disease 
progression) will amplify rates of transmission in clinics and, in particular, rates of 
transmission that result in disease. In this paper, we use mathematical modelling to 
determine the potential effects of that amplification on the proportion of disease that 
results from clinic-based transmission, using South Africa as a case study. Our model is not 
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designed to give an estimate of the proportion of tuberculosis that results from clinic-based 
transmission in any particular setting in South Africa, but instead gives an indication of the 
extent of the effects that increased contact time in clinics in people with HIV and/or 






We used an individual-based model, written in Netlogo 6.0.111. Full details of the model 
structure and parameter values are given in the supplementary material Model description 
and Figure S1. 
Simulated individuals could be uninfected with Mtb, have a latent infection, have smear-
negative disease, have smear-positive disease, or be receiving tuberculosis treatment. 
Treatment was assumed to always be successful. 
HIV was included in the model as a binary variable, with simulated individuals either being 
HIV positive or HIV negative. 12.7% of individuals were assumed to be HIV positive, in line 
with the estimated HIV prevalence in South Africa in 201712. 
Overall, 1% of contact time in the model occurs in clinics, with the other 99% occurring in a 
homogenous ‘other locations’, representing all other settings. Contacts are defined as any 
people ‘sharing air’ in an indoor location or transport, as these are the contacts thought to 
be most relevant for Mtb transmission13, 14. Random mixing was assumed between people in 
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clinics and in other locations. Each simulated individual had the same contact rate. The ratio 
of contact time in clinics of HIV-positive individuals compared to HIV-negative individuals, 
and of people with tuberculosis compared to people without tuberculosis, could be varied, 
while keeping the overall proportion of contact time that occurred in clinics and the contact 
rate of each simulated individual constant.  
A paediatric population, with different risks of disease progression and different contact 
patterns, was not simulated. 
 
Increased clinic visiting in HIV-positive people and people with tuberculosis 
629 parameter combinations were created where the rate ratio of clinic visiting in HIV-
positive people compared to HIV-negative people (RRHIV) varied from 1 to 10 in increments 
of 0.25, and where the rate ratio of clinic visiting in people with infectious tuberculosis 
compared to people without infectious tuberculosis (RRTB) varied from 1 to 5 in increments 
of 0.25. Maximum rate ratios of 10 and 5 were chosen based on expert opinion, as plausible 
upper bounds for the majority of settings. All combinations of the two ratios were 
simulated. The rate ratio of clinic visiting in people with both HIV and tuberculosis relative 
to people with neither HIV nor tuberculosis was assumed to be equal to max(RRHIV, RRTB) + 
0.5*min(RRHIV, RRTB) – 0.5. In other words, it was assumed having both HIV and untreated 
tuberculosis would require some extra clinic visits (or longer clinic visits) compared to 
having just one of the conditions, but it would not require as many as the sum of those 




For each parameter combination, the model was run for 50 years to allow equilibrium to be 
reached. The model was then run for a further 950 years, and the results averaged over the 
950 years and 10 model runs. 
Calibration 
The model was fitted to estimates of overall tuberculosis incidence in South Africa and the 
proportion of incident tuberculosis that occurred in HIV-positive people in 201715. 
Scenarios 
Low and high clinic-based transmission scenarios were generated, to determine plausible 
ranges for the proportion of transmission that occurs in clinics for each parameter 
combination. 
Three characteristics of the model were changed in the scenarios: 
1. The proportion of incident tuberculosis that was in HIV-positive people was changed 
from 60% in the main scenarios to 55% and 64% in the low and high clinic-based 
transmission scenarios respectively (proportions equal to the best estimate and low 
and high bounds from World Health Organization (WHO) incidence estimates15). 
2. In the main scenario, the proportion of HIV-positive and HIV-negative people with 
tuberculosis who had smear-positive disease was 35% and 45%, respectively; these 
were changed to 30% and 50%, and to 40% and 40%, in the low and high clinic-based 
transmission scenarios, respectively16. 
3. The rate ratio of clinic visiting in people with both HIV and tuberculosis relative to 
people with neither HIV nor tuberculosis (RRHIV_tuberculosis) was assumed to be equal to 




Univariate sensitivity analyses where each factor was varied individually were also 
conducted; these results are given in the supplementary material.  
All data used came from published sources, and no ethical approval was required. 
Results 
Fit to data 
Figure 1 shows the model fit to the tuberculosis incidence estimates and the estimated 
proportion of incident disease that is in HIV positive people in each scenario. Figure S2 
shows the model fit in the sensitivity analyses. For all scenarios and parameter 
combinations, the modelled tuberculosis incidence was well within the lower and upper 
bounds of the estimated empirical incidence, and the proportion of incident disease that 
was in HIV-positive people was within ±2% (absolute difference) of the desired value. The 
proportion of contact that occurs in clinics for people without and without HIV and 
tuberculosis is shown in Figures S3-S5 
Proportion of transmission in clinics 
Figure 2 shows the estimated proportion of disease that resulted from transmission 
occurring in clinics overall, in HIV-positive people, and in HIV-negative people, in the best, 
low, and high clinic-based transmission scenarios. With RRHIV = 10 and RRTB = 5, an estimated 
10.7% (8.5%–13.4% in low and high scenarios) of disease resulted from clinic-based 
transmission overall, 16.3% (14.0%–19.2%) in HIV-positive people, and 1.9% (1.5%–2.2%) in 
HIV-negative people. With RRHIV = 5 and RRTB = 2, an estimated 5.3% (4.3%–6.3%) of disease 
resulted from clinic-based transmission overall, 7.7% (6.7%–8.8%) in HIV-positive people, 




Our results show that the small proportions of contact time that occur in clinics may greatly 
underrate their importance to tuberculosis incidence in high burden settings with high HIV 
prevalences. Despite only 1% of contact time occurring in clinics in our model, 10.7% of 
disease overall and 16.3% in HIV-positive people resulted from transmission in clinics when 
we simulated clinic contact 10 times higher in HIV-positive people compared with HIV-
negative people, and five times higher in people with infectious tuberculosis compared to 
people without. With clinic contact five times higher in HIV-positive people and two times 
higher in people with infectious tuberculosis, 5.3% of disease overall and 7.7% of disease in 
HIV-positive people resulted from transmission in clinics. 
We did not explicitly simulate drug sensitive and drug resistant tuberculosis. It is plausible 
however, that clinic-based transmission may be higher for drug resistant disease than for 
drug susceptible disease, due to more clinic visits being required before the patient starts 
effective treatment and becomes uninfectious. 
Our findings demonstrate the importance of minimising the potential for clinic-based Mtb 
transmission. Ensuring that adequate infection control measures are implemented in clinics 
is critical to this, but our results also suggest two other strategies for reducing clinic-based 
transmission. The first is reducing the number of visits that people with tuberculosis make 
to clinics before diagnosis and starting effective treatment. The second is reducing the 
amount of contact that HIV-positive people have at clinics, through reducing the mean 
number of people present at clinics and/or reducing time spent at clinics. This could be 
achieved through increasing the time between clinics visits for people on stable ART, or 
reducing clinic waiting times for people attending HIV clinics. 
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We fitted our model to data from South Africa, which has a high prevalence of HIV. A similar 
amplification of disease resulting from transmission in clinics may also be found in settings 
with much lower HIV prevalences, due to the presence of other risk factors for tuberculosis, 
such as diabetes and undernutrition. The magnitude of the amplification is likely to be 
smaller, however, as the effect of most other risk factors on the risk of tuberculosis disease 
development is lower than that of HIV17. 
Our results are intended to give an indication of the extent of the effects that increased 
contact in clinics in people with tuberculosis and HIV positive people are likely to have on 
tuberculosis from transmission in clinics, rather than an estimate of the proportion of 
tuberculosis that results from clinic-based transmission in South Africa. For that reason, we 
simulated an arbitrary 1% of contact time occurring in clinics, to allow comparisons to be 
easily made between the proportion of contact and the proportion of disease, and present 
results over a wide range of different values of RRHIV and RRTB. We also kept the overall 
amount of contact constant for people with and without tuberculosis and HIV, and did not 
model contact patterns by age. 
We simulated random mixing in both clinics and in all other locations. This assumption is 
likely to be reasonable for clinics, with different people being present each time a person 
visits a clinic. It will be less reasonable for some other locations however, in particular 
homes, workplaces, and schools, where high proportions of contact time occur. Contact 
saturation may reduce transmission in these locations, increasing the proportion of 
transmission that occurs in clinics18. We may therefore have underestimated the 
contribution of clinics to tuberculosis incidence. Conversely, clustering of people with HIV 
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and TB in locations other than clinics may have meant that we overestimated the 
contribution of clinics. 
We made the assumption in our model that there was no difference between clinics and 
other types of congregate settings in indoor ventilation levels. There is limited empirical 
data on ventilation levels in congregate settings in South Africa. One study found that the 
proportion of room air that had previously been exhaled by other room occupants was 
similar in a clinic waiting room and in other indoor congregate settings in KwaZulu-Natal, 
South Africa; this measure is impacted both by occupancy and ventilation levels19. If 
ventilation levels are higher or lower in clinics, then we will have over- or under-estimated 
the importance of clinics to transmission. 
We did not explicitly simulate HIV disease progression or ART, and therefore did not model 
how clinic visiting behaviour may vary between HIV-positive people. If susceptibility to 
developing tuberculosis is higher for HIV-positive people who frequently attend clinics than 
for HIV-positive people who do not (e.g. people with lower CD4 counts spend more time at 
clinics than people with higher CD4 counts), then we will have underestimated the 
proportion of disease that results from clinic-based transmission for a given RRHIV. 
Alternatively, if the susceptibility to developing tuberculosis is lower for HIV-positive people 
who frequently attend clinics than for HIV-positive people who do not (e.g. HIV-positive 
people on ART visit clinics more frequently than those not on ART), then we will have 
overestimated the proportion of disease that results from clinic-based transmission for a 
given RRHIV. We also did not simulate variation in infectiousness for people with tuberculosis 
(beyond smear status). If clinic visiting increases as the disease progresses and people 
become more infectious, then we may have underestimated transmission in clinics. 
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The proportion of incident tuberculosis that was in HIV-positive people in the model varied 
slightly between different parameter combinations within the same scenario (Figure 1), 
increasing as the value of RRHIV increased. This will have resulting in us slightly 
overestimating the extent to which the proportion of disease that results from clinic-based 
transmission increases as RRHIV increases. The effect of this bias will be small however, as 
the increase in the proportion of incident tuberculosis in HIV-positive people was small. In 
addition to this, in the low and high clinic-based transmission scenarios, for some values of 
RRHIV and RRTB, the proportion of incident tuberculosis that was in HIV-positive people was 
slightly outside the range of WHO estimates15. This was an inevitable consequence of fitting 
to the lower and upper bounds of the range in the low and high clinic-based transmission 
scenarios respectively and, while it may have changed the results slightly, it will have had no 
effect on the overall conclusions of this paper. 
To conclude, we demonstrate in this paper that although only small amounts of contact 
time may occur in clinics, this may greatly underestimate the contribution of clinics to 
tuberculosis disease in high tuberculosis/HIV burden settings. Future work to generate 
empirical estimates of how much HIV and infectious tuberculosis increase clinic visiting in 
different settings would allow improved estimates to be made of the contribution of clinic-
based transmission to tuberculosis burden, and of the potential impact on community-wide 
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Figure 1. Model fit to a) tuberculosis incidence and b) the proportion of incident 
tuberculosis in HIV positive people, in the best, low, and high scenarios. Box hinges indicate 
the upper, middle and lower quartiles of the values in each parameter set, and whiskers 
extend to the upper and lower ranges of the values. The horizontal dashed lines show the 






Figure 2. Proportion of disease resulting from transmission in clinics overall (1st column), in 
HIV positive people (2nd column) and in HIV negative people (3rd column) in the best (1st 
row), low (2nd row), and high (3rd row) clinic-based transmission scenarios 
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